...
首页> 外文期刊>Digestive disease interventions. >Endoscopic Management of Gastroesophageal Reflux Disease
【24h】

Endoscopic Management of Gastroesophageal Reflux Disease

机译:内镜胃食管反流的管理疾病

获取原文
获取原文并翻译 | 示例
           

摘要

Gastroesophageal reflux disease (GERD) occurs in up to 20% of the population. Effective management of the condition is essential to reduce both symptoms and the risk for dysplastic changes of esophageal mucosa. Although lifestyle and diet modification and proton-pump inhibitors (PPIs) remain the standard of therapy, approximately 30% of patients experience persistent or recurrent symptoms with this therapy, which has been labeled PPI-refractory GERD. Surgical antireflux procedures have long been the standard therapy for PPI-refractory GERD, but drawbacks include cost and surgical morbidity. Endoscopic techniques for GERD management have been developed over the past 20 years including transoral incisionless fundoplication, the Stretta procedure, and antireflux mucosectomy. This article will review the current literature on each of these endoscopic procedures as well as highlight areas where further research is needed to fully understand the best practices for use of these endoscopic techniques for the management of PPI-refractory GERD.
机译:胃食管反流病(GERD)发生多达20%的人口。的条件是至关重要的减少症状和发育异常的变化的风险食管粘膜。修改和服用ppi抑制剂(质子泵抑制剂)保持标准的治疗,大约30%的病人经历持续或复发性症状与治疗,一直PPI-refractory GERD的标签。程序一直是标准的治疗PPI-refractory GERD,但缺点包括成本和手术发病率。GERD的技术管理在过去的20年里,包括开发的经口incisionless fundoplication,Stretta过程和antireflux mucosectomy。本文将回顾当前的文学在每一个内窥镜以及程序强调需要进一步研究的领域完全理解的最佳实践的使用这些内窥镜技术的管理PPI-refractory盖德。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号